Identified a novel G1456E mutation in the SCN4A gene associated with Paramyotonia Congenita of von Eulenburg, providing an important genotype-phenotype correlation.
This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Paramyotonia congenita (PMC) of von Eulenburg is an autosomal dominant muscular disease characterized by exercise- and cold-induced myotonia and weakness. To date, 18 missense mutations in the adult skeletal muscle sodium channel alpha-subunit (SCN4A) gene have been identified to cause a spectrum of muscular diseases, including PMC of von Eulenburg, PMC without cold paralysis, potassium-aggravating myotonia, and hyperkalemic periodic paralysis. However, no obvious correlations can be made between the location or nature of amino acid substitutions in SCN4A and its clinical phenotypes. OBJECTIVE: To describe clinical and genetic features of a family with PMC of von Eulenburg. RESULTS: A Japanese family with cold-induced myotonia and weakness was diagnosed as having PMC of von Eulenburg. This phenotype was identified to be caused by a novel mutation that substituted a glutamic acid residue for a highly conserved glycine residue in the fourth transmembrane segment (S4) of domain IV. This predicted a decrease in positive charge specific for the S4. CONCLUSION: In addition to the G1456E identified in this study, 4 mutations that cause a decrease in positive charge in the S4/D4 are associated with the phenotype of PMC of von Eulenburg. This provides an important genotype-phenotype correlation in sodium channelopathies.
Answers are grounded in this paper and cite their sources.
Expands SCN4A spectrum in paramyotonia congenita; hypothesis-generating for genotype-phenotype links pending validation.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: